Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fespixon Cream for Chronic Diabetic Foot Ulcers in Dialysis Patients
NCT05338463Phase 4Completed
- Sponsor
- Cathay General Hospital
- Start
- Dec 2021
- Primary completion
- Mar 2024
- Modality
- Botanical drug
- Countries
- 1
01
Overview
A Phase 4 trial of Fespixon in diabetic foot ulcer (DFU), sponsored by Cathay General Hospital. Started Dec 2021; status: completed.
02
Drugs
Fespixon
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT05338463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05338463.